🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study

Rita Nanda, Laura Q.M. Chow et al. (2016)

Journal of Clinical Oncology

1.3K citesjournal articlePDF

The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

Andrew G. Nicholson, Ming S. Tsao et al. (2022)

Journal of Thoracic Oncology

1.4K citesjournal articlePDF

Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience

Andrew Seidman, Clifford Hudis et al. (2002)

Journal of Clinical Oncology

1.3K citesjournal articlePDF

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

I F Tannock, D Osoba et al. (1996)

Journal of Clinical Oncology

1.3K citesjournal articlePDF

MicroRNAs in body fluids—the mix of hormones and biomarkers

Maria Angelica Cortez, Carlos Bueso-Ramos et al. (2011)

Nature Reviews Clinical Oncology

1.3K citesjournal articlePDF

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011

Q. T. Ostrom, H. Gittleman et al. (2014)

Neuro-Oncology

1.3K citesjournal articlePDF

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma

Yuri E. Nikiforov, Raja R. Seethala et al. (2016)

JAMA Oncology

1.3K citesjournal articlePDF

Targeting the Wnt/β-catenin signaling pathway in cancer

Ya Zhang, Xin Wang (2020)

Journal of Hematology & Oncology

1.3K citesjournal articlePDF

Randomized Trial of Laparoscopic-Assisted Resection of Colorectal Carcinoma: 3-Year Results of the UK MRC CLASICC Trial Group

David G. Jayne, Pierre J. Guillou et al. (2007)

Journal of Clinical Oncology

1.3K citesjournal articlePDF

Treatment With the Radiolabeled Somatostatin Analog [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate: Toxicity, Efficacy, and Survival

Dik J. Kwekkeboom, Wouter W. de Herder et al. (2008)

Journal of Clinical Oncology

1.3K citesjournal articlePDF

The global burden of lung cancer: current status and future trends

Amanda Leiter, Rajwanth R. Veluswamy et al. (2023)

Nature Reviews Clinical Oncology

1.5K citesjournal articlePDF

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer

Kiyoyuki Furuse, Masahiro Fukuoka et al. (1999)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

H.J. Schmoll, E. Van Cutsem et al. (2012)

Annals of Oncology

1.3K citesjournal articlePDF

Targeting PI3K/Akt/mTOR Signaling in Cancer

Camillo Porta, Chiara Paglino et al. (2014)

Frontiers in Oncology

1.3K citesjournal article

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

M.C. Liu, G.R. Oxnard et al. (2020)

Annals of Oncology

1.3K citesjournal articlePDF